Table 3

Incidence of significant (>3 or ≥4) or severe pain (≥7) from Visual Analogue Scale scores

PVB
n (%)
TEB
n (%)
RR (95% CI)*
Average chest pain overall >3
 3 months5/25 (20.0)6/21 (28.6)0.7 (0.2 to 2.0)
 6 months2/27 (7.4)5/25 (20.0)0.4 (0.1 to 1.7)
Average chest pain overall ≥4
 3 months5/25 (20.0)4/21 (19.0)1.1 (0.3 to 3.4)
 6 months1/27 (3.7)3/25 (12.0)0.3 (0.03 to 2.8)
Average chest pain overall ≥7
 3 months0/25 (−)2/21 (10.0)–†
 6 months0/27 (−)1/25 (4.0)–†
Worst chest pain overall >3
 3 months9/24 (37.5)7/23 (30.4)1.2 (0.6 to 2.8)
 6 months7/27 (25.9)11/26 (42.3)0.6 (0.3 to 1.3)
Worst chest pain overall ≥4
 3 months8/24 (33.3)7/23 (30.4)1.1 (0.5 to 2.5)
 6 months7/27 (25.9)9/26 (34.6)0.75 (0.3 to 1.7)
Worst chest pain overall ≥7
 3 months6/24 (25.0)5/23 (21.7)1.2 (0.4 to 3.3)
 6 months2/27 (7.4)5/26 (19.2)0.4 (0.1 to 1.8)
  • *RR <1 indicates less incidence with PVB.

  • †Unable to estimate.

  • PVB, paravertebral blockade; RR, relative risk; TEB, thoracic epidural blockade.